VBI Vaccines
VBIV
$0.58
Share price
2.30%
Change (1 day)
-79.84%
Change (1 year)
Categories
EPS for VBI Vaccines (VBIV)
EPS in 2023 (TTM): -$13.80
According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is -$13.80. In 2022 the company made an earnings per share (EPS) of -$13.18 a decrease over its 2021 EPS that were of -$8.10.
EPS history for VBI Vaccines from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$13.80 | 4.7% |
| 2022 | -$13.18 | 62.69% |
| 2021 | -$8.10 | 28.57% |
| 2020 | -$6.30 | -53.33% |
| 2019 | -$13.50 | -53.61% |
| 2018 | -$29.10 | 10.23% |
| 2017 | -$26.40 | 22.22% |
| 2016 | -$21.60 | -94.55% |
| 2015 | -$396.01 | 728.93% |
| 2014 | -$47.77 | 92.1% |
| 2013 | -$24.87 | -66.24% |
| 2012 | -$73.67 | -77.97% |
| 2011 | -$334.43 | 217.82% |
| 2010 | -$105.23 | 954.43% |
| 2009 | -$9.98 | -2273.56% |
| 2008 | $0.46 | -209.82% |
| 2007 | -$0.42 | -42.44% |
| 2006 | -$0.73 | -82.2% |
| 2005 | -$4.08 | 2797.22% |
| 2004 | -$0.14 | -41.9% |
| 2003 | -$0.24 | -99.17% |
| 2002 | -$29.35 | 8.12% |
| 2001 | -$27.14 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | -$1.00 | -92.75% | 🇺🇸 USA |
 Curis CRIS | -$10.00 | -27.52% | 🇺🇸 USA |
 Myriad Genetics MYGN | -$3.04 | -77.97% | 🇺🇸 USA |